StonvexLoading…
StonvexStonvexStonvexCore line items from CRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.91B | $2.54B | $2.15B | $2.64B |
Operating Income | $598.00M | $620.00M | $808.00M | $812.00M |
Net Income | $363.00M | $376.00M | $564.00M | $524.00M |
EPS (Diluted) | $4.15 | $4.62 | $7.78 | $6.75 |
Total Assets | $7.40B | $7.13B | $4.00B | $3.97B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $132.00M | $372.00M | $496.00M | $307.00M |
Free Cash Flow OCF − CapEx | $543.00M | $355.00M | $468.00M | $311.00M |
Shares Outstanding | 88.75M | 91.10M | 68.69M | 71.95M |